Journal of Inflammation Research, published by Dove Medical Press Ltd, is a premier open-access journal dedicated to advancing the field of immunology and allergy, with a particular focus on the biological mechanisms underlying inflammation. Since its inception in 2008, this journal has provided a vital platform for researchers to share their findings and foster collaboration within the global scientific community. With an impressive 2023 impact factor placing it in the Q2 category for both Immunology and Immunology and Allergy, the journal has consistently maintained its relevance and high academic standards, ranking #100 in Medicine (Immunology and Allergy) and #118 in Immunology (Immunology and Microbiology) according to Scopus metrics. The E-ISSN 1178-7031 allows for easy access to a plethora of pioneering research articles, reviews, and clinical studies that address contemporary issues in inflammation and immunity. As a leading resource for researchers, professionals, and students alike, Journal of Inflammation Research is committed to facilitating the dissemination of groundbreaking discoveries that contribute to improved therapeutic strategies and health outcomes.

Immunity, Inflammation and Disease is a premier open-access journal published by WILEY, dedicated to advancing the field of immunology and allergy. Launched in 2013, this journal has established itself as a significant platform for researchers and professionals to disseminate high-quality research findings and innovative insights that address critical issues in immune responses and inflammatory diseases. With an impact factor that reflects its growing influence and a current ranking in Q3 for Immunology and Q2 for Immunology and Allergy, this journal serves a diverse audience keen on exploring cutting-edge developments. Researchers are encouraged to submit their work to share their findings with a global reach, foster collaboration, and enhance the understanding of immune mechanisms and therapeutic strategies. Accessible since its inception, Immunity, Inflammation and Disease is committed to open science, ensuring that vital research is freely available for the advancement of knowledge within the academic community and beyond.

GENES AND IMMUNITY, published by SpringerNature, is a leading scholarly journal dedicated to advancing the field of genetics and immunology. With an impressive impact factor and a distinguished ranking in the Q1 quartile of both Genetics and Immunology disciplines for 2023, this journal serves as a pivotal platform for researchers and professionals looking to explore the intricate relationships between genetic factors and immune responses. Established in 1999 and continuously published until 2024, it features high-quality peer-reviewed research articles, reviews, and commentary that address critical issues and recent advancements in the field. The journal adheres to rigorous academic standards, evidenced by its strong Scopus rankings, making it a valuable resource for students, researchers, and practitioners alike who are seeking to deepen their understanding of genetics' role in immunity. For those looking to keep abreast of cutting-edge insights, GENES AND IMMUNITY is an essential read.

Innate Immunity, published by SAGE Publications Ltd, serves as a vital platform for disseminating cutting-edge research in the fields of immunology, microbiology, cell biology, and infectious diseases. With an ISSN of 1753-4259 and an E-ISSN of 1753-4267, this journal has been a prominent contributor to the academic community since its inception in 1996, focusing on the innate immune response and its implications for health and disease. Holding a respectable impact factor and categorized in the Q2 and Q3 quartiles across various relevant domains, Innate Immunity ranks competitively in major databases, including Scopus, where it appears in the top 75th percentile for Infectious Diseases. Researchers and professionals are encouraged to explore its wealth of articles that are pivotal in bridging fundamental immunology with clinical applications, fostering a deeper understanding of immune mechanisms vital for combating human diseases.

MOLECULAR IMMUNOLOGY, published by Pergamon-Elsevier Science Ltd in the United Kingdom, is a highly regarded journal in the fields of Immunology and Molecular Biology. With a focus on advancing the understanding of the immune system at the molecular level, the journal has been a critical resource since its inception in 1975. The journal is currently listed in the second quartile (Q2) of its category as per the 2023 rankings, indicating its substantial impact in both Immunology and Molecular Biology research. Researchers and professionals benefit from the journal's rigorous peer-review process and its commitment to publishing high-quality original research, reviews, and methodological studies that explore the intricate dynamics of immune responses. Although it does not currently offer an open access option, MOLECULAR IMMUNOLOGY remains an essential platform for scholars, emphasizing the significance of molecular interactions within the immune system and their implications in health and disease.

IMMUOLOGY LETTERS, published by Elsevier, is a distinguished journal in the field of immunology, focusing on the latest advancements and findings that significantly influence immunological research and clinical applications. Established in 1979, the journal has evolved to cater to a global readership, featuring high-quality peer-reviewed articles across a diverse spectrum of topics related to immunity and allergic responses. With an impressive Q2 category ranking in both Immunology and Allergy as of 2023, it holds a strong position within the scientific community, evidenced by its commendable Scopus rankings (Rank #71/233 in Medicine - Immunology and Allergy and Rank #85/236 in Immunology and Microbiology - Immunology). While primarily subscription-based, the journal aims to foster knowledge dissemination that encourages collaboration among researchers and practitioners alike, making significant contributions to the understanding of immune mechanisms. The journal is integral for educators, students, and professionals aiming to stay abreast of current trends and breakthroughs in the immune system's intricate functions.

TRENDS IN IMMUNOLOGY, published by CELL PRESS, stands as a premier source of insights and developments within the field of immunology. With an ISSN of 1471-4906 and E-ISSN of 1471-4981, this journal has established a strong reputation, evidenced by its prestigious status in Q1 quartiles for both Immunology and Allergy in 2023. It is ranked #13 out of 233 in the Scopus category of Medicine – Immunology and Allergy, and #16 out of 236 in Immunology and Microbiology, placing it within the top 94th and 93rd percentiles respectively. Since its inception in 1987, TRENDS IN IMMUNOLOGY has provided a critical platform for researchers, professionals, and students to access the latest advancements and integrative reviews in immunological research. The journal offers open access options, enhancing the accessibility of its high-impact content to a global audience. Researchers and practitioners rely on its pages not only for cutting-edge findings but also for comprehensive discussions that drive the future of immunology research.

Clinical and Experimental Immunology, published by Oxford University Press, is a premier journal that has been a cornerstone in the field of immunology since its inception in 1966. With an ISSN of 0009-9104 and an E-ISSN of 1365-2249, this journal holds a significant position in academic research, currently ranking in the Q2 category for both Immunology and Allergy (2023). Its impactful contributions are reflected in its Scopus rankings, where it stands at Rank #63 out of 233 in Immunology and Allergy, placing it in the 73rd percentile, and Rank #73 out of 236 in Immunology and Microbiology. Researchers, healthcare professionals, and students will find this journal an invaluable resource for cutting-edge studies, reviews, and clinical advancements in the ever-evolving domain of immunology. While the publication does not offer open-access options, it remains a pivotal platform for disseminating knowledge that impacts both clinical practice and experimental research.

The Annual Review of Immunology, published by Annual Reviews, is a premier journal that has been contributing to the field of immunology since its establishment in 1983. With a strong reputation highlighted by its impressive impact factor and top-tier rankings—holding the Q1 category in both Immunology and Immunology and Allergy, alongside significant Scopus Rankings—this journal serves as an essential resource for researchers, professionals, and students alike. The Annual Review of Immunology covers the latest advancements and critical developments in the domain, fostering a better understanding of immune responses and disorders. Although it is not an open-access journal, it provides comprehensive reviews that synthesize emerging data and trends, making it indispensable for those at the forefront of immunological research. With volumes anticipated through 2024, it continues to set the standard for high-quality scholarly publications in the field.

Cellular & Molecular Immunology is a prestigious peer-reviewed journal published by the CHIN SOCIETY IMMUNOLOGY. As a leading journal in the fields of immunology and infectious diseases, it proudly holds a Q1 designation across multiple categories, including Immunology, Allergy, and Medicine (Miscellaneous), reflecting its commitment to excellence and impactful research. With an ISSN of 1672-7681 and an E-ISSN of 2042-0226, the journal has been essential reading since its inception in 2004, continuously gathering insights from cutting-edge studies. It ranks impressively within Scopus, with positions in the 7th, 8th, and 9th percentile in relevant categories, establishing it as a cornerstone for researchers, clinicians, and students alike. The journal offers an extensive range of original research articles, reviews, and clinical studies, ensuring that readers stay at the forefront of immunological discovery. Whether you are interested in basic immunology, infectious diseases, or evolving therapies, Cellular & Molecular Immunology serves as an invaluable resource for advancing your knowledge and engagement in this dynamic field.